In silico drug discovery of IKK-β inhibitors from 2-amino-3-cyano-4-alkyl-6-(2-hydroxyphenyl) pyridine derivatives based on QSAR, docking, molecular dynamics and drug-likeness evaluation studies

1. Hammoudi, N.-E.-H.
2. Benguerba, Y.
3. Attoui, A.
4. Hognon, C.
5. Lemaoui, T.
6. Sobhi, W.
7. Benaicha, M.
8. Badawi, M.
9. Monari, A.